Recent advances in TRPV4 agonists and antagonists.
Recent advances in TRPV4 agonists and antagonists.
Bioorg Med Chem Lett. 2020 Feb 08;:127022
Authors: Lawhorn BG, Brnardic EJ, Behm DJ
Abstract
TRPV4 is a ubiquitously expressed, non-selective cation channel activated by a range of stimuli including hypotonicity, temperature, pH, stretch and endogenous ligands. Agents that modulate TRPV4 are sought as potential therapeutics for the treatment of many diseases including osteoarthritis, respiratory illnesses, gastrointestinal disorders, pain and congestive heart failure. In recent years, significant advances in TRPV4 drug discovery have been realized as at least seven novel TRPV4 agonist or antagonist templates were reported and the first selective TRPV4 antagonist was evaluated in early clinical trials.
PMID: 32063431 [PubMed - as supplied by publisher]
Source: Bioorganic and Medicinal Chemistry Letters - Category: Chemistry Authors: Lawhorn BG, Brnardic EJ, Behm DJ Tags: Bioorg Med Chem Lett Source Type: research
More News: Cardiology | Chemistry | Clinical Trials | Congestive Heart Failure | Gastroenterology | Heart | Heart Failure | Legislation | Osteoarthritis | Pain | Respiratory Medicine